Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9GX7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,377
Award facts
- Contract value 100% obligated
- $17,376.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,376.73 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml) on December 22, 2025, with completion scheduled for December 23, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical and medical commodities globally to support military healthcare programs.
AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a critical federal vendor specializing in pharmaceutical distribution and healthcare solutions for military and veteran medical systems. The company's performance under its DLA prime vendor contract demonstrates capability across diverse therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies. This delivery order for Pulmozyme—a medication used in cystic fibrosis treatment—exemplifies the company's role in fulfilling specialized pharmaceutical requirements for the Defense Health Agency and broader federal healthcare systems through its extensive supply network.
Quick answers
Who was awarded contract SPE2DR26F9GX7?
SPE2DR26F9GX7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F9GX7 worth?
The government has obligated $17,377 on SPE2DR26F9GX7.
Is contract SPE2DR26F9GX7 an order under another contract?
Yes. SPE2DR26F9GX7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GX7 competed?
The extent of competition for SPE2DR26F9GX7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award